Who owns Amylyx Pharmaceuticals, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of AMLX from SEC Form 13F filings across 230 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 230 institutions disclosed 132.3M shares of Amylyx Pharmaceuticals, Inc. worth $3.85B — about 111.2% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
230
13F holders
$3.85B
value, 2026 filers
111.2%
of shares outstanding (132.3M sh)
62
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of AMLX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 19.9M | $580.4M | 0.0% | 16.8% | +19.2% |
| 2 | PERCEPTIVE ADVISORS LLC | 10.6M | $307.7M | 5.4% | 8.9% | +26.9% |
| 3 | BlackRock, Inc. | 10.4M | $301.7M | 0.0% | 8.7% | +17.5% |
| 4 | TCG Crossover Management, LLC | 6.2M | $181.7M | 5.1% | 5.2% | 0.0% |
| 5 | Driehaus Capital Management LLC | 5.4M | $158.0M | 1.1% | 4.6% | +78.7% |
| 6 | Janus Henderson Group Ltd.NEW | 5.4M | $157.0M | 0.1% | 4.5% | new |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 5.1M | $147.8M | 0.0% | 4.3% | +20.2% |
| 8 | Saturn V Capital Management LP | 4.5M | $130.1M | 19.0% | 3.8% | -3.3% |
| 9 | RA CAPITAL MANAGEMENT, L.P.NEW | 4.3M | $124.5M | 1.2% | 3.6% | new |
| 10 | First Light Asset Management, LLC | 4.0M | $116.0M | 6.9% | 3.4% | +31.9% |
| 11 | FRANKLIN TEMPLETON INC | 3.9M | $115.6M | 0.0% | 3.3% | +33.3% |
| 12 | GOLDMAN SACHS GROUP INC | 3.6M | $104.4M | 0.0% | 3% | +25.5% |
| 13 | JPMORGAN CHASE & CO | 3.4M | $100.7M | 0.0% | 2.9% | +84.3% |
| 14 | PRICE T ROWE ASSOCIATES INC /MD/ | 3.1M | $90.6M | 0.0% | 2.6% | +2045.5% |
| 15 | MORGAN STANLEY | 2.8M | $81.3M | 0.0% | 2.3% | -10.7% |
| 16 | STATE STREET CORP | 2.7M | $79.1M | 0.0% | 2.3% | +4.4% |
| 17 | GEODE CAPITAL MANAGEMENT, LLC | 2.7M | $77.4M | 0.0% | 2.2% | +13.9% |
| 18 | Siren, L.L.C. | 2.5M | $72.2M | 1.7% | 2.1% | +67.5% |
| 19 | Commodore Capital LP | 2.0M | $58.2M | 4.5% | 1.7% | -64.6% |
| 20 | VANGUARD PORTFOLIO MANAGEMENT LLC | 1.2M | $34.2M | 0.0% | 1% | +10.9% |
| 21 | 683 Capital Management, LLC | 1.1M | $33.5M | 1.4% | 1% | -10.1% |
| 22 | Woodline Partners LP | 1.1M | $33.4M | 0.1% | 1% | +35.5% |
| 23 | DEUTSCHE BANK AG\ | 1.1M | $31.2M | 0.0% | 0.9% | +92.4% |
| 24 | NORTHERN TRUST CORP | 963,871 | $28.0M | 0.0% | 0.8% | +15.9% |
| 25 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 916,169 | $26.7M | 0.0% | 0.8% | +26.4% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.